JPS53130698A - Esters of 1*44ethanoo100hydroxyy 55oxoo5hh*1*benzopyrano*3*44b* pyridine - Google Patents

Esters of 1*44ethanoo100hydroxyy 55oxoo5hh*1*benzopyrano*3*44b* pyridine

Info

Publication number
JPS53130698A
JPS53130698A JP2554378A JP2554378A JPS53130698A JP S53130698 A JPS53130698 A JP S53130698A JP 2554378 A JP2554378 A JP 2554378A JP 2554378 A JP2554378 A JP 2554378A JP S53130698 A JPS53130698 A JP S53130698A
Authority
JP
Japan
Prior art keywords
55oxoo5hh
benzopyrano
pyridine
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2554378A
Other languages
English (en)
Japanese (ja)
Inventor
Roido Arendosen Debitsudo
Erumaa Zooku Harorudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of JPS53130698A publication Critical patent/JPS53130698A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
JP2554378A 1977-03-14 1978-03-08 Esters of 1*44ethanoo100hydroxyy 55oxoo5hh*1*benzopyrano*3*44b* pyridine Pending JPS53130698A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77775677A 1977-03-14 1977-03-14

Publications (1)

Publication Number Publication Date
JPS53130698A true JPS53130698A (en) 1978-11-14

Family

ID=25111162

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2554378A Pending JPS53130698A (en) 1977-03-14 1978-03-08 Esters of 1*44ethanoo100hydroxyy 55oxoo5hh*1*benzopyrano*3*44b* pyridine

Country Status (13)

Country Link
JP (1) JPS53130698A (el)
AU (1) AU516613B2 (el)
CA (1) CA1095519A (el)
CH (1) CH628633A5 (el)
DE (1) DE2810801A1 (el)
DK (1) DK111378A (el)
FR (1) FR2383948A1 (el)
GB (1) GB1577304A (el)
GR (1) GR65603B (el)
NO (1) NO780880L (el)
PH (1) PH13723A (el)
SE (1) SE7802841L (el)
ZA (1) ZA781074B (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2645021A1 (fr) * 1989-03-30 1990-10-05 Sanofi Sa Utilisation d'un agoniste potassique dans le traitement du glaucome
KR980008226A (ko) * 1996-07-05 1998-04-30 다케다 쿠니오 시각기능장애의 예방 및 치료제

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493579A (en) * 1967-05-29 1970-02-03 Little Inc A 1,4-ethano-5h-(1)benzopyrano (3,4-b)pyridines
US3905969A (en) * 1974-01-17 1975-09-16 Sharps Ass Heterocyclic esters of 5H-{8 1{9 benzopyrano{8 3,4-b{9 pyridines

Also Published As

Publication number Publication date
DK111378A (da) 1978-09-15
FR2383948A1 (fr) 1978-10-13
AU3371878A (en) 1979-09-06
AU516613B2 (en) 1981-06-11
CH628633A5 (en) 1982-03-15
CA1095519A (en) 1981-02-10
FR2383948B1 (el) 1981-07-31
SE7802841L (sv) 1978-09-15
GR65603B (en) 1980-10-14
DE2810801A1 (de) 1978-09-21
GB1577304A (en) 1980-10-22
ZA781074B (en) 1979-04-25
PH13723A (en) 1980-09-09
NO780880L (no) 1978-09-15

Similar Documents

Publication Publication Date Title
GB2006709B (en) Production of micro-capsules
JPS5455584A (en) Production of 22ketoo 1*44diazacycloalkanes
JPS5481274A (en) Manufacture of oosubstituted derivative of ****cyanidanee33ol
JPS5424886A (en) Production of 1*2*44 triazinee55one derivative
GB2008572B (en) Manufacture of esters
JPS54109928A (en) Manufacture of 2*44difluoroaniline
JPS5452012A (en) Manufacture of 1*1*1*22tetrafluoroethane
JPS5452019A (en) Manufacture of 1*33dihydroxyy22aminopropane
ZA782481B (en) Manufacture of esters
JPS5452082A (en) Manufacture of 2*3*55trichloropyridine
ZA781292B (en) Manufacture of esters
JPS53130698A (en) Esters of 1*44ethanoo100hydroxyy 55oxoo5hh*1*benzopyrano*3*44b* pyridine
JPS5332195A (en) Production of *bachulol* derivative
JPS5488238A (en) Manufacture of alphaacyanobenzyl esters
JPS5414982A (en) Production of 55fluorouracil derivative
JPS5581A (en) Production of 211hydroxyy 200methylpregnane derivative
JPS5419963A (en) Production of 2*55 furandicarbonitrile
GB2009178B (en) Manufacture of esters
JPS5430159A (en) Improved production of nn*33sulfamyll44 chlorobtnzamide**22 methylindoline
JPS549260A (en) Production of 2*55 furandialdehyde
JPS5398903A (en) Bissdithiocarbamate ester of diilower alkylformal
JPS541148A (en) Production of *chikatabi*
JPS549217A (en) Bisshydroxydiester of 2*2*4*44 tetraalkylbutanee1*33diol
JPS5439064A (en) Production of pervocide derivative
JPS545980A (en) Production of 22substituted tetrahydropiridine derivative